Major heart study to determine best treatments
This article was originally published in Clinica
A multimillion-dollar trial comparing treatments for coronary artery disease is due to begin in the US in October. The five-year trial is designed to distinguish between those patients who should undergo invasive treatments, such as angioplasty, and those for whom drug treatment alone would be sufficient.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.